-
Private equity's new target could be good news for ASCs
After years of courting ASCs, gastroenterology groups and ophthalmology groups, private equity has set its sights on cardiology, a high-acuity growth opportunity for ASCs. -
Private equity won't lose its grip on ASC market
Private equity has weaved its way into ASCs, and healthcare experts don't expect it to go anywhere. -
Private equity and ASCs: 5 updates in a month
Here are five private equity updates to know since Nov. 22: -
How private equity dug deeper into the ASC industry in 2022
Private equity has made a name for itself in the ASC industry in recent years, and ASC leaders expect to see the trend continue. -
Private equity & ASCs: 6 updates to know
Here are six private equity updates since Oct. 6 ASC leaders need to know: -
3 fast facts on private equity
Here are three stats on private equity's healthcare boom: -
'Every day there is a new player in the ASC space': 5 leaders weigh in on private equity
Five leaders joined Becker's to discuss private equity's influence in the ASC industry: -
EyeSouth Partners acquired by a private equity firm and 4 more PE updates
Here are five private equity updates since Sept. 21 that ASC leaders need to know: -
EyeSouth Partners to be purchased by private equity firm
Private equity firm Olympus Partners inked an agreement to acquire ophthalmology management services organization EyeSouth Partners. -
Private equity turns to ophthalmology with billion-dollar deals
Private equity firms are seeing increasing opportunity in ophthalmology firms, reflected in the increase in multimillion-dollar investments in the industry in recent years, Kaiser Health News reported Sept. 19. -
Private equity boom: 5 moves for ASC leaders to know
Here are five private equity moves to know since Sept. 2: -
EyeSouth partners completes 31st affiliation
EyeSouth partners has completed an affiliation with Raleigh Ophthalmology, the organization's 31st affiliation, and its first in North Carolina, according to a Sept. 6 press release shared with Becker's. -
Private equity & ASCs: 5 updates in the last 2 weeks
Here are five updates on private equity since Aug. 4 that ASC leaders need to know: -
Private equity healthcare deals have plummeted in 2022, report says
The number of private equity-backed healthcare deals has significantly declined in the first half of the year, according to findings from New York City-based consulting firm Oliver Wyman. -
The downside of private equity for physicians
While private equity investment can provide stable funding and allow practices to be innovative, it may be incompatible with physician practice ethics and sustainability, the American Medical Association wrote in a recent blog post. -
Private equity's ASC focus: 6 updates from the last 2 weeks
Six private equity updates for ASCs since July 18: -
Top 6 hot spots for private equity-owned physician practices
Washington, D.C., Arizona and New Jersey are the top three hot spots for private equity firms acquiring physician practices, according to a study published in JAMA Health Forum. -
Dermatology backed most by private equity
Across six specialties, 4.9 percent of physicians worked in private equity-backed practices in 2019, according to a study published in JAMA Health Forum. -
Private equity's growing influence: 3 ASC leaders' thoughts
Increasing consolidation and COVID-19 have accelerated private equity's interest in ASCs. -
Private equity: 4 updates in 2 weeks
Here are four private equity updates since July 12 that ASC leaders should keep an eye on:
Page 5 of 50